Current Price
Target Price
Qwest Corporation, an integrated communications company, provides communications services to business and residential customers in Arizona, Colorado, Idaho, Iowa, Minnesota, Montana, Nebraska, New Mexico, North Dakota, O...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
| Metric (B) | FY 2026 | FY 2026 | FY 2027 |
|---|---|---|---|
| $-1.37 | $-4.74 | $-3.03 | |
| 0.01 | 0.02 | 0.02 | |
| — | — | — |
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | BBambusa Th... | BBTX | $819.66M | — | — | — | — | — | — |
| 2. | MMentari Th... | MTRI | $1.08B | — | — | — | — | — | — |
| 3. | OObsidian T... | OBX | $775.88M | — | — | — | — | — | — |
| 4. | LLatigo Bio... | LTGO | $869.18M | — | 2.22 | — | — | — | — |
| 5. | TFirst Trac... | TRAXV | $782.20M | — | 2.36 | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) | Sep 18 | Dec 18 | Mar 19 | Jun 19 | Sep 19 | Dec 19 | Mar 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|
Revenue | 2,149 | 2,113 | 2,055 | 2,051 | 2,039 | 2,012 | 1,918 | 524 |
COGS | 697 | 661 | 607 | 588 | 630 | 613 | 473 | 490 |
Gross Profit | 1,452 | 1,452 | 1,448 | 1,463 | 1,409 | 1,399 | 1,445 | 34 |
Gross Profit % | 67.57% | 68.72% | 70.46% | 71.33% | 69.1% | 69.53% | 75.34% | 6.49% |
| 1,432 | 1,428 | 1,295 | 1,301 | 1,291 | -3,228 | 143 | 139 | |
EBIT | 717 | 685 | 760 | 750 | 748 | 626 | 779 | 679 |
OPM % | 33.36% | 32.42% | 36.98% | 36.57% | 36.68% | 31.11% | 40.62% | 129.58% |
Non-Operating Income | -153 | -108 | -102 | -106 | -105 | -103 | -99 | -96 |
PBT | 564 | 577 | 658 | 644 | 643 | 523 | 680 | 583 |
Income Tax | 111 | 172 | 171 | 167 | 166 | 137 | 177 | 153 |
Tax Rate % | 19.68% | 29.81% | 25.99% | 25.93% | 25.82% | 26.2% | 26.03% | 26.24% |
Net Income | 453 | 405 | 487 | 477 | 477 | 386 | 503 | 430 |
NPM % | 21.08% | 19.17% | 23.7% | 23.26% | 23.39% | 19.18% | 26.23% | 82.06% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8,848 | 8,753 | 8,838 | 8,964 | 8,910 | 8,550 | 8,493 | 8,157 | 2.78 | 13.56 |
COGS | 2,868 | 2,790 | 2,879 | 2,872 | 2,934 | 2,881 | 2,767 | 2,438 | 0 | 0 |
Gross Profit | 5,980 | 5,963 | 5,959 | 6,092 | 5,976 | 5,669 | 5,726 | 5,719 | 0 | 0 |
Gross Profit % | 67.59% | 68.13% | 67.42% | 67.96% | 67.07% | 66.3% | 67.42% | 70.11% | - | - |
| 6,943 | 6,675 | 6,726 | 6,704 | 6,588 | 6,237 | 5,833 | 659 | 31.87 | 73.48 | |
EBIT | 1,905 | 2,078 | 2,112 | 2,260 | 2,322 | 2,313 | 2,660 | 2,884 | -29.09 | -59.92 |
OPM % | 21.53% | 23.74% | 23.9% | 25.21% | 26.06% | 27.05% | 31.32% | 35.36% | -1047.16% | -441.84% |
Non-Operating Income | -514 | -512 | -503 | -527 | -559 | -522 | -501 | -416 | 1.25 | 1.42 |
PBT | 1,391 | 1,566 | 1,609 | 1,733 | 1,763 | 1,791 | 2,159 | 2,468 | -27.84 | -58.51 |
Income Tax | 542 | 602 | 639 | 659 | 678 | 134 | 494 | 641 | 0 | 0 |
Tax Rate % | 38.96% | 38.44% | 39.71% | 38.03% | 38.46% | 7.48% | 22.88% | 25.97% | - | - |
Net Income | 849 | 964 | 970 | 1,074 | 1,085 | 1,657 | 1,665 | 1,827 | -27.84 | -58.51 |
NPM % | 9.6% | 11.01% | 10.98% | 11.98% | 12.18% | 19.38% | 19.6% | 22.4% | -1002.02% | -431.39% |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 8 | 14 | 6 | 3 | 5 | 1 | 5 | 2 | 126.9 | 112.79 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 1,565 | 1,737 | 1,840 | 1,599 | 1,701 | 1,768 | 1,841 | 2,484 | 2 | 4.08 | |
| 15,141 | 14,259 | 20,611 | 19,868 | 19,443 | 19,100 | 18,737 | 18,513 | 16.45 | 32.9 | |
Total Assets | 16,714 | 16,010 | 22,457 | 21,470 | 21,149 | 20,869 | 20,583 | 20,999 | 145.35 | 149.77 |
| 10,050 | 10,050 | 10,050 | 10,050 | 10,050 | 10,050 | 10,050 | 10,050 | 0 | 0 | |
| -76 | -437 | -867 | -1,143 | -1,358 | -713 | -182 | 67 | -29.43 | -84.66 | |
| 7,625 | 7,558 | 7,379 | 7,239 | 7,261 | 7,281 | 5,959 | 5,951 | 10.28 | 41.87 | |
| 1,512 | 1,537 | 1,620 | 1,854 | 1,976 | 1,877 | 1,909 | 2,009 | 2.54 | 3.62 | |
| 4,834 | 4,510 | 4,275 | 3,470 | 3,220 | 2,374 | 2,847 | 2,922 | 161.97 | 188.93 | |
Total Liabilities | 23,945 | 23,218 | 22,457 | 21,470 | 21,149 | 20,869 | 20,583 | 20,999 | 145.35 | 149.77 |
Consolidated Figures in Millions / View Standalone.
| Period (M) | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2,774 | 2,713 | 2,801 | 2,591 | 2,652 | 2,435 | 3,791 | 3,332 | -20.39 | -41.61 | |
| -1,528 | -1,381 | -1,251 | -1,220 | -1,334 | -1,436 | -1,153 | -1,723 | 0 | 0 | |
| -1,241 | -1,326 | -1,558 | -1,374 | -1,316 | -1,003 | -2,634 | -1,612 | 149.44 | 30.86 | |
Net CFNet Cash Flow | 5 | 6 | -8 | -3 | 2 | -4 | 4 | -3 | 129.05 | -10.75 |
FCFFree Cash Flow | 1,508 | 1,449 | 1,636 | 1,344 | 1,393 | 1,107 | 2,751 | 2,277 | -23.93 | -44.02 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.5% | 9.8% | 10.3% | 11.9% | 12.3% | 18.4% | 17.3% | 18.3% | -0.6% | 102.6% | |
| 0.76 | 0.79 | 0.80 | 0.81 | 0.84 | 0.78 | 0.60 | 0.59 | - | -0.37 | |
| 0.56 | 0.65 | 0.82 | 0.66 | 0.61 | 0.81 | 0.81 | 0.73 | 6.21 | 3.07 | |
| 0.52 | 0.53 | 0.46 | 0.41 | 0.42 | 0.41 | 0.41 | 0.39 | 0.00 | 0.09 | |
Cash Conversion | 3.27 | 2.81 | 2.89 | 2.41 | 2.44 | 1.47 | 2.28 | 1.82 | 0.73 | 0.71 |
Payout Ratio | 135.5% | 137.4% | 144.3% | 125.7% | 119.8% | 60.4% | 76.6% | 87.6% | - | - |
| 33.4% | -1.1% | 1.0% | 1.4% | -0.6% | -4.0% | -0.7% | -4.0% | -100.0% | 388.2% | |
| - | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | - | |
| 6.00 | 8.00 | 6.00 | 8.00 | 7.00 | 7.00 | 9.00 | 6.00 | 3.00 | 2.00 | |
| -2.89 | -2.96 | -2.74 | -2.87 | -2.80 | -2.69 | -3.08 | -2.89 | -3.22 | 0.08 | |
| 75.00 | 80.00 | 80.00 | 80.00 | 80.00 | 85.00 | 85.00 | 85.00 | - | - | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | -10.0% | -4.3% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns City Therapeutics Inc, from SEC filings
Schedule 13D / 13G filers (5%+), plus stakes City Therapeutics Inc holds in others · open a holder to see each filing
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Holding company | DE | 7,025,543 | 14.00% | SC 13G · 6 Nov 2026 | |
| Individual | R1 | 4,342,866 | 8.10% | SC 13G · 22 Oct 2026 | |
| Partnership | DE | 3,727,005 | 7.00% | SC 13G · 26 Oct 2026 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Month | Insiders | Shares sold | Value sold | Shares bought | Value bought | Awards, tax, gifts |
|---|---|---|---|---|---|---|
| 3 | — | — | 340,000 | $6.1M | 22,219,189 |
Form 4, filed within two business days of each trade. Sales and purchases are open-market; awards, tax withholding, gifts and option exercises are grouped. Amended filings are left out so a restated trade isn't counted twice.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 822,840 | 2.27 | ||
| 30 Nov 2020 | 21,267 | -65.5% | 1.00 | |
| 13 Nov 2020 | 61,612 | -25.0% | 1.94 | |
| 30 Oct 2020 | 82,117 | +27.3% | 1.99 | |
| 15 Oct 2020 | 64,506 | -9.6% | 1.69 | |
| 30 Sep 2020 | 71,318 | +11.9% | 1.17 | |
| 15 Sep 2020 | 63,743 | +277.7% | 1.16 | |
| 31 Aug 2020 | 16,878 | -10.6% | 1.00 | |
| 14 Aug 2020 | 18,883 | +49.6% | 1.00 | |
| 31 Jul 2020 | 12,626 | +3.9% | 1.00 | |
| 15 Jul 2020 | 12,157 | -16.5% | 1.00 | |
| 30 Jun 2020 | 14,561 | +24.5% | 1.00 | |
| 15 Jun 2020 | 11,696 | +22.7% | 1.00 | |
| 29 May 2020 | 9,532 | -22.2% | 1.00 | |
| 15 May 2020 | 12,247 | +4.1% | 1.00 | |
| 30 Apr 2020 | 11,766 | -73.3% | 1.00 | |
| 15 Apr 2020 | 44,107 | +49.1% | 1.00 | |
| 31 Mar 2020 | 29,587 | -22.5% | 1.00 | |
| 13 Mar 2020 | 38,162 | +43.2% | 1.00 | |
| 28 Feb 2020 | 26,649 | +210.2% | 1.00 | |
| 14 Feb 2020 | 8,591 | -18.0% | 1.00 | |
| 31 Jan 2020 | 10,481 | +22.2% | 1.00 | |
| 15 Jan 2020 | 8,574 | +86.2% | 1.00 | |
| 31 Dec 2019 | 4,604 | -79.8% | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
City Therapeutics Inc's SEC filings and earnings call transcripts
What recent news says about City Therapeutics Inc, scored for sentiment.